BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,645,410 | -20.3% | 176,084 | -3.8% | 0.14% | -16.5% |
| Q2 2023 | $8,336,387 | +11.0% | 182,976 | -1.1% | 0.16% | +9.3% |
| Q1 2023 | $7,507,494 | -22.0% | 185,096 | -2.0% | 0.15% | -23.1% |
| Q4 2022 | $9,627,774 | -7.1% | 188,891 | -1.9% | 0.20% | -12.2% |
| Q3 2022 | $10,366,000 | -20.9% | 192,456 | -5.7% | 0.22% | -15.3% |
| Q2 2022 | $13,105,000 | -17.3% | 204,026 | -0.2% | 0.26% | +0.4% |
| Q1 2022 | $15,851,000 | -15.6% | 204,421 | -6.5% | 0.26% | -6.8% |
| Q4 2021 | $18,771,000 | +4.8% | 218,676 | -1.8% | 0.28% | +1.8% |
| Q3 2021 | $17,906,000 | -6.7% | 222,632 | -6.6% | 0.28% | -4.8% |
| Q2 2021 | $19,195,000 | -6.9% | 238,450 | -2.4% | 0.29% | -12.4% |
| Q1 2021 | $20,615,000 | +0.1% | 244,425 | -4.8% | 0.33% | -5.4% |
| Q4 2020 | $20,597,000 | -5.3% | 256,695 | -5.1% | 0.35% | -18.1% |
| Q3 2020 | $21,748,000 | -19.8% | 270,435 | -14.1% | 0.43% | -22.1% |
| Q2 2020 | $27,114,000 | +4.3% | 314,913 | -1.7% | 0.55% | -11.3% |
| Q1 2020 | $26,007,000 | -2.7% | 320,326 | +0.3% | 0.62% | +30.7% |
| Q4 2019 | $26,717,000 | -47.5% | 319,505 | -45.1% | 0.47% | -49.0% |
| Q3 2019 | $50,925,000 | +95.3% | 582,203 | +82.8% | 0.93% | +101.3% |
| Q2 2019 | $26,081,000 | -0.3% | 318,447 | -1.1% | 0.46% | -2.1% |
| Q1 2019 | $26,172,000 | +19.5% | 321,878 | -3.3% | 0.47% | +7.3% |
| Q4 2018 | $21,908,000 | -14.7% | 332,843 | -0.2% | 0.44% | +7.4% |
| Q3 2018 | $25,698,000 | +3.5% | 333,348 | -0.9% | 0.41% | -1.9% |
| Q2 2018 | $24,838,000 | +11.5% | 336,373 | -1.8% | 0.42% | +9.2% |
| Q1 2018 | $22,269,000 | -11.0% | 342,389 | -11.6% | 0.38% | -10.6% |
| Q4 2017 | $25,024,000 | -4.6% | 387,129 | -7.4% | 0.43% | -7.0% |
| Q3 2017 | $26,232,000 | -8.2% | 418,039 | -11.5% | 0.46% | -8.4% |
| Q2 2017 | $28,582,000 | +4.3% | 472,125 | -10.6% | 0.50% | +2.5% |
| Q1 2017 | $27,402,000 | +15.6% | 528,381 | -1.2% | 0.49% | +9.9% |
| Q4 2016 | $23,713,000 | -15.3% | 534,790 | -9.1% | 0.44% | -11.7% |
| Q3 2016 | $27,996,000 | +4.6% | 588,141 | -0.6% | 0.50% | +3.7% |
| Q2 2016 | $26,766,000 | -27.8% | 591,900 | -34.4% | 0.48% | -23.9% |
| Q1 2016 | $37,093,000 | -1.3% | 902,945 | -8.3% | 0.64% | +3.6% |
| Q4 2015 | $37,568,000 | +11.8% | 984,747 | -3.7% | 0.62% | +15.2% |
| Q3 2015 | $33,606,000 | -54.1% | 1,023,017 | -2.2% | 0.53% | -46.1% |
| Q2 2015 | $73,155,000 | +4.6% | 1,046,124 | +2.5% | 0.99% | +17.3% |
| Q1 2015 | $69,917,000 | -5.8% | 1,020,691 | +0.8% | 0.84% | -2.4% |
| Q4 2014 | $74,207,000 | +6.1% | 1,012,516 | +3.9% | 0.87% | +8.0% |
| Q3 2014 | $69,923,000 | -1.4% | 974,267 | -0.7% | 0.80% | +5.5% |
| Q2 2014 | $70,917,000 | -1.6% | 980,872 | +0.2% | 0.76% | -0.5% |
| Q1 2014 | $72,054,000 | +14.3% | 979,255 | +8.0% | 0.76% | +13.4% |
| Q4 2013 | $63,038,000 | +46.0% | 906,370 | +37.9% | 0.67% | +33.5% |
| Q3 2013 | $43,169,000 | +11.7% | 657,160 | +17.8% | 0.50% | -0.2% |
| Q2 2013 | $38,650,000 | – | 557,960 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |